アステラス薬：Astellas Receives Positive CHMP Opinion for XOSPATA (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia - 有報キャッチャー

アステラス薬（4503）　Astellas Receives Positive CHMP Opinion for XOSPATA (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia 2019/09/24

/-

読み込み中…